C79.49
Secondary malignant neoplasm of other parts of nervous system
Clinical Classification Guidelines
Medical Intelligence & Overview
Secondary malignant neoplasm of the nervous system, classified under ICD-10 code C79.49, refers to cancerous tumors that have spread to parts of the nervous system from other primary locations in the body. These metastatic tumors are the result of cancer cells traveling through the bloodstream or lymphatic system, establishing new malignant growths in the nervous system's different areas. Recognizing this condition is crucial for determining appropriate treatment options and managing symptoms effectively. Although this diagnosis indicates advanced cancer, modern medical approaches aim to improve quality of life and prolong survival.
Causes & Symptoms
Clinical Causes: Primary cancers elsewhere in the body that have metastasized to the nervous system Spread from cancers of the lung, breast, melanoma, or other organs that can invade nerve tissues Circulating tumor cells that travel through blood or lymph to reach and grow within nervous tissue Genetic and environmental factors that make certain cancers more prone to metastasize to the nervous system
Key Symptoms: Headaches that may worsen over time Seizures or convulsions Neurological deficits such as weakness or numbness in limbs Difficulty with coordination and balance Changes in vision, speech, or consciousness Persistent nausea or vomiting Unexplained mental changes or personality shifts Localized pain in areas affected by tumors
Diagnostic & Treatment
Diagnosis Path: Diagnosis of secondary malignant neoplasm of the nervous system involves a combination of clinical evaluation and specialized testing. Imaging studies are pivotal and may include MRI (Magnetic Resonance Imaging) and CT (Computed Tomography) scans to visualize tumor locations and assess their extent. In some cases, a biopsy may be performed to confirm the diagnosis and determine the tumor type. Additional procedures like lumbar punctures can assess if cancer has spread into the cerebrospinal fluid. Laboratory tests may also help identify primary cancer sources.
Treatment Protocols: Radiation therapy to target specific tumor sites and control symptoms Chemotherapy to attack cancer cells systemically, which can help shrink tumors Targeted therapy that focuses on specific genetic markers of cancer Steroids to reduce swelling and alleviate neurological symptoms Supportive care including pain management and rehabilitation services Surgical intervention may be considered in certain cases to remove accessible tumors or relieve pressure
Clinical Advice & FAQs
Billing Guidance
Is C79.49 a billable ICD-10 code?
Yes, C79.49 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C79.49?
Clinical documentation must specify the nature of Secondary malignant neoplasm of other parts of nervous system and any associated comorbidities for accurate reporting.
Cite this Clinical Reference